Ryan C. Heniford/LinkedIn
Oct 14, 2025, 05:26
Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
Ryan C. Heniford, Director of Global Business Development and Technical Marketing at Evonik, shared a post on LinkedIn:
”Today is World Thrombosis Day! A reminder that thrombosis prevention isn’t just about medication, it’s also about smarter medical devices.
That’s where Evonik’s Endexo technology comes in.
It’s an innovative passive surface modification that makes catheter surfaces inherently more biocompatible — no coatings, no drugs, no leaching.
Key benefits at a glance:
- Up to 99 % reduction in thrombus accumulation
- Less protein and platelet adhesion → reduced clot risk
- Lower friction for smoother handling and less trauma
- Durable performance because Endexo® is part of the polymer itself
On World Thrombosis Day, it’s worth remembering that every thrombus prevented is a patient protected — and that innovation in materials science plays a crucial role in that.”
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
